Usha R.
Usha R. Gowrishetty, Louisville, KY US
Patent application number | Description | Published |
---|---|---|
20100308791 | SINGLE ELEMENT THREE TERMINAL PIEZORESISTIVE PRESSURE SENSOR - Embodiments of the invention provide for three-terminal pressure sensors (“3-TPS”), a method of measuring a pressure with a 3-TPS, and a method of manufacturing a 3-TPS. In some embodiments, the 3-TPS includes a semiconducting layer with cavity and a 3-TPS element having at least one piezoresistive layer overlapping at least a portion of the cavity and oriented at an angle selected to provide a desired sensitivity for the 3-TPS. The method of measuring a pressure with a 3-TPS is performed with a 3-TPS that includes an input terminal, first and second output terminals, and a 3-TPS element, the 3-TPS element overlapping at least a portion of a cavity at a predetermined angle. The method comprises providing an input signal to the input terminal of the 3-TPS, determining a difference between two output signals from the respective output terminals of the 3-TPS, and correlating the determined difference to a pressure. | 12-09-2010 |
Usha R. Pathipati, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20090246302 | COMPOSITION AND METHOD FOR PROTECTING AGRICULTURAL CROPS AND/OR AGRICULTURAL PRODUCTS - The present invention provides a composition and a method for protecting agricultural crops and/or agricultural products against insects/pests. The said composition comprising an effective amount of extract obtained from | 10-01-2009 |
Usha R. Pendurthi, Tyler, TX US
Patent application number | Description | Published |
---|---|---|
20150366939 | SUPPRESSION OF MALIGNANT MESOTHELIOMA BY OVEREXPRESSION OR STIMULATION OF ENDOTHELIAL PROTEIN C RECEPTORS (EPCR) - The influence of TF, endothelial cell protein C receptor (EPCR) and protease activated receptor-1 (PAR1) on tumor growth of malignant pleural mesothelioma (MPM) is disclosed. MPM cells that lack or express TF, EPCR or PAR1 and a murine orthotopic model of MPM led to the discovery that intrapleural administration into nude mice of REN MPM cells expressing TF and PAR1 but lacking EPCR and PAR2 generated large pleural cavity tumors. Suppression of TF or PAR1 expression markedly reduced tumor growth. Overexpression of TF in non-aggressive MPM cells expressing EPCR and PAR1 but exhibiting minimal levels of TF failed to alter their tumorigenicity. Introduction of EPCR expression in aggressive MPM cells attenuated tumor growth whereas EPCR silencing in non-aggressive MPM cells overexpressing TF increased tumorigenicity of non-aggressive cells. Expression of EPCR by MPM cells suppresses tumor growth and treats MPM. | 12-24-2015 |